Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Macrodantin, Macrobid, Nitrofuran MAC (Show all)
Generic Name: Nitrofurantoin
Nitrofurantoin is an antibiotic that is used to prevent and treat urinary tract infections caused by susceptible strains of E. coli, S. aureus, Enterococcus, Klebsiella, and Enterobacter.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Bladder problems | 38 | 5 |
|
|
|
||
| UTI symptoms | 27 | 13 |
|
|
|
|
|
| Prevent infection | 26 | 4 |
|
|
|||
| Other | 14 | 3 |
|
|
|||
| Support urinary health | 3 | 1 |
|
||||
| Recurring Urinary Tract Infection UTI | 2 | 0 |
See all 92 patients currently taking Nitrofurantoin
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Nitrofurantoin
| Fatigue | 1 | |
|---|---|---|
| Excessive daytime sleepiness (somnolence) | 1 | |
| Yeast Infection (candida) | 1 | |
| Diarrhea | 1 | |
| Diarrhea chronic | 1 | |
| Stomach problems | 1 |
Frequently reported dosages based on patients currently taking Nitrofurantoin. See all 22 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 25 | ||
| Doctor's advice | 7 | ||
| Other | 6 | ||
| Side effects too severe | 2 | ||
| Did not seem to work | 1 | ||
| Personal research | 1 |
Adherence
Taking treatment as prescribed
Adherence of Nitrofurantoin
Always |
22 | 79% |
|
|---|---|---|---|
Usually |
4 | 14% |
|
Sometimes |
1 | 4% |
|
Never |
1 | 4% |
|
Burden
Difficulty being on treatment
Burden of Nitrofurantoin
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
3 | 11% |
|
A little |
2 | 7% |
|
Not at all |
23 | 82% |
|
Cost
Paid out of pocket
Cost of Nitrofurantoin
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 6% |
|
$25-49 |
2 | 13% |
|
< $25 |
13 | 81% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 22, 2012.